Glenmark, FDC Recall Hypertension, Glaucoma Drugs in US Farhat Nasim17 Feb 2025 8:17 PM ISTNew Delhi: Drug firms Glenmark Pharmaceuticals and FDC Ltd are recalling products in the US market due to manufacturing issues, according to the US...
Beta-blockers may reduce all-cause mortality in HFpEF patients Aditi19 Jan 2024 11:30 AM ISTAccording to the American and European heart failure guidelines, HFpEF is defined as a condition with LVEF >=50% and accompanying signs and...
Carvedilol fails to prevent heart failure in anthracycline-exposed survivors of childhood cancer: PREVENT-HF trial Medha Baranwal16 Jan 2024 3:30 AM ISTUSA: A randomised, controlled, phase 2b trial (PREVENT-HF) has shed light on the effect of carvedilol versus placebo on cardiac function in...
Carvedilol better at lowering risk of arrhythmias among recipients of ICD compared to metaprolol Medha Baranwal22 Sept 2023 11:45 AM ISTUSA: Carvedilol can significantly reduce the risk of atrial arrhythmias (ATA) when compared to metoprolol in heart failure (HF) patients with...
Carvedilol more effective than non selective beta blockers in reducing portal hypertension Dr. Kamal Kant Kohli11 July 2023 9:15 AM ISTPortal hypertension (PH) is characterized by elevated pressure in portal venous system. The most common cause of portal hypertension is cirrhosis...
Long-term carvedilol therapy reduces decompensation risk among cirrhosis patients Dr. Shravani Dali19 Oct 2022 7:30 PM ISTCarvedilol significantly decreases the risk of decompensation in patients with cirrhosis and clinically significant portal hypertension (CSPH),...
Metoprolol not tied to clinically relevant high blood sugar in diabetics with HF: Study Medha Baranwal29 Jun 2021 9:00 AM ISTUSA: Initiation of metoprolol versus carvedilol is not associated with an increase in the risk of clinically relevant hyperglycemia or high blood...
Carvedilol improves survival in cirrhosis patients: Study Medha Baranwal5 March 2021 8:45 AM ISTUK: The use of carvedilol improves overall survival in patients with cirrhosis and portal hypertension, finds a recent study in the...
Carvedilol tied to improved survival in cirrhosis patients: Study Medha Baranwal27 Jan 2021 3:07 PM ISTUK: Carvedilol improves survival in patients with cirrhosis and portal hypertension, suggests a recent study in the journal Alimentary Pharmacology...
Bisprolol safer than carvedilol in Hemodialysis patients for lowering HF, stroke risk: Study Dr Kartikeya Kohli10 Jan 2021 8:21 PM ISTPersons with end-stage kidney disease (ESKD) undergoing dialysis are at high risk of developing and dying from cardiovascular (CV) disease, for which...
